MedPath

The effect of denosumab for the treatment of osteoporosis in hemodialysis patients

Not Applicable
Conditions
Osteoporosis
Registration Number
JPRN-UMIN000014458
Lead Sponsor
Saiseikai Kumamoto Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Patient who have the contraindication for denosumab.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in bone mineral density (BMD) at lumbar supine and femoral neck and TRACP-5b
Secondary Outcome Measures
NameTimeMethod
Change in Ca, P, intact-PTH and side effect
© Copyright 2025. All Rights Reserved by MedPath